Music Therapy in Sickle Cell Transition Study



Status:Active, not recruiting
Conditions:Anemia
Therapuetic Areas:Hematology
Healthy:No
Age Range:18 - 23
Updated:4/21/2016
Start Date:June 2015
End Date:August 2016

Use our guide to learn which trials are right for you!

The Effects of Music Therapy on Transition Outcomes in Young Adult Patients With Sickle Cell Disease

The purpose of this study is to investigate the effects of the BEATS Music Therapy Program
on the self-efficacy, trust, knowledge, and adherence of young adult patients with sickle
cell disease during transition.

Primary Hypotheses:

Compared to baseline, young adult patients with sickle cell disease who receive the music
therapy interventions will report:

1. Higher sickle cell self-efficacy as measured by the Sickle Cell Self Efficacy Scale
(SCSES),

2. Higher trust in health care providers as measured by the Wake Forest Trust in the
Medical Profession Scale, and

3. Higher sickle cell disease knowledge as measured by the Seidman Sickle Cell Knowledge
Quiz.

Secondary Hypotheses

1. Compared to the one year prior to the study period, young adults with sickle cell disease
who receive the music therapy interventions will have a higher rate of adherence to clinic
appointments during the one-year study period.

Additional Questions

1. Do music therapy interventions influence attendance to scheduled blood transfusions?

2. Do music therapy interventions influence the rate of hospital utilization as measured
by Emergency Department visits, Acute Care Clinic visits, and admissions during the
study period compared to the previous year?

3. Do music therapy interventions influence adherence to hydroxyurea therapy for patients
receiving hydroxyurea as measured by change in mean corpuscular volume (MCV) during the
study period?

4. Do music therapy interventions influence adherence to iron chelation therapy for
patients receiving iron chelation therapy as measured by ferritin count during the
study period?


Inclusion Criteria:

- Subject is between 18 and 23 years of age

- Subject is diagnosed with sickle cell disease

- Subject is able to speak and understand English

- Subject is currently scheduled for quarterly appointments in the Bridge Clinic

Exclusion Criteria:

- Subject has significant hearing impairment that has not been corrected

- Subject has significant visual impairment that has not been corrected
We found this trial at
1
site
?
mi
from
Cleveland, OH
Click here to add this to my saved trials